Read news on Liver fibrosis with our app.
Read more in the app
Heart and metabolic risk factors more strongly linked to liver fibrosis in women than men, study finds - EurekAlert!
Unexpected Drug Combo Reverses Liver Fibrosis
A repurposed drug duo shows powerful synergy against liver fibrosis - EurekAlert!
Discovery of a cellular communication network that accelerates liver fibrosis - EurekAlert!
Hydronidone for the treatment of liver fibrosis associated with chronic hepatitis B - EurekAlert!
Statin use and risk of hepatocellular carcinoma and liver fibrosis in chronic liver disease - EurekAlert
Pitt study identifies potential new treatment for liver fibrosis - EurekAlert
Researchers identify potential new strategy to slow the development of liver fibrosis
Liver fibrosis as an independent cardiovascular risk factor in non-alcoholic fatty liver disease - EurekAlert
Study finds targeting inflammation may not help reduce liver fibrosis in MAFLD
Mitochondrial GRIM19 loss induces liver fibrosis through NLRP3/IL33 activation via reactive oxygen species/NF-кB ... - EurekAlert
Scientists discover a new signaling pathway and design a novel drug for liver fibrosis
Scientists discover a new signaling pathway and design a novel drug for liver fibrosis - EurekAlert
Hormones have the potential to treat liver fibrosis
Liver fibrosis: Giant cells step in to compensate for impaired immune function
